Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15486323 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Niacin to Improve Blood Flow in People With Sickle Cell Disease
Condition: Sickle Cell Disease
Interventions: Drug: Niacin-ER;   Drug: Placebo;   Drug: L-NMMA;   Drug: Acetylcholine

Study has passed its completion date and status has not been verified in more than two years.